Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Adenocarcinoma”

955 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 955 results

Testing effectiveness (Phase 2)Study completedNCT00002475
What this trial is testing

Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerColorectal CancerKidney Cancer+3 more
St. Vincent Medical Center - Los Angeles 40
Testing effectiveness (Phase 2)Study completedNCT03947151
What this trial is testing

Efficacy and Tolerance of an Ovarian Stimulation Protocol Combining Follicle Stimulating Hormone (FSH) and Degarelix Acetate in Female Candidates for Fertility Preservation Before Chemotherapy for Breast Cancer

Who this might be right for
Invasive Ductal Breast Carcinoma
Assistance Publique - Hôpitaux de Paris 8
Early research (Phase 1)Study completedNCT03000257
What this trial is testing

Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
AbbVie 182
Testing effectiveness (Phase 2)Study completedNCT00918281
What this trial is testing

Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of (18F) Injection

Who this might be right for
Solid TumorsHigh Grade GliomasLung Cancer+4 more
GE Healthcare 70
Early research (Phase 1)Ended earlyNCT02784795
What this trial is testing

LY3039478 in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid TumorBreast CancerColon Cancer+2 more
Eli Lilly and Company 94
Not applicableStudy completedNCT01686412
What this trial is testing

Determination of Autonomic Responses to Exposure to Electromagnetic Fields With Low Energy Modulated Frequency

Who this might be right for
Hepatocellular CarcinomaBreast Cancer
Hospital Sirio-Libanes 60
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Not applicableStudy completedNCT00182728
What this trial is testing

Radiation Therapy During Surgery in Treating Older Women With Invasive Breast Cancer

Who this might be right for
Breast Cancer
UNC Lineberger Comprehensive Cancer Center 89
Early research (Phase 1)Study completedNCT05585034
What this trial is testing

Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomaMelanoma Excluding Uveal MelanomaNon-small Cell Lung Cancer, Squamous or Non-squamous+6 more
Xencor, Inc. 60
Large-scale testing (Phase 3)Looking for participantsNCT01185132
What this trial is testing

Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy

Who this might be right for
Breast Cancer
Rocky Mountain Cancer Centers 660
Large-scale testing (Phase 3)Ended earlyNCT00097344
What this trial is testing

The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

Who this might be right for
Breast NeoplasmsNeoplasms, Hormone-Dependent
Intarcia Therapeutics 842
Early research (Phase 1)Temporarily pausedNCT05958199
What this trial is testing

NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7

Who this might be right for
Metastatic Malignant Neoplasm
NextPoint Therapeutics, Inc. 131
Early research (Phase 1)Looking for participantsNCT04521764
What this trial is testing

A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Invasive Breast CarcinomaMetastatic Breast Adenocarcinoma+2 more
Mayo Clinic 54
Not applicableUnknownNCT03517332
What this trial is testing

Circulating Tumor DNA Exposure in Peripheral Blood

Who this might be right for
Colorectal CancerPancreatic AdenocarcinomaGastric Cancer+8 more
Quantgene Inc. 10,000
Not applicableStudy completedNCT00569543
What this trial is testing

Effect of Tamoxifen or an Aromatase Inhibitor on Estrogen Metabolism in Women Treated for Newly Diagnosed Breast Cancer

Who this might be right for
Breast Cancer
University of Nebraska 27
Not applicableStudy completedNCT00898508
What this trial is testing

Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease

Who this might be right for
Breast Cancer
City of Hope Medical Center 563
Early research (Phase 1)Study completedNCT00003548
What this trial is testing

Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity

Who this might be right for
Cancer
NYU Langone Health 20
Testing effectiveness (Phase 2)Study completedNCT02694809
What this trial is testing

The PROMISE Study: Duavee in Women With DCIS

Who this might be right for
Ductal Breast Carcinoma In SituPostmenopausal
Northwestern University 142
Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Testing effectiveness (Phase 2)Active Not RecruitingNCT04551495
What this trial is testing

Neoadjuvant Study of Targeting ROS1 in Combination With Endocrine Therapy in Invasive Lobular Carcinoma of the Breast (ROSALINE)

Who this might be right for
Invasive Lobular Breast CarcinomaER+ Breast CancerHER2-negative Breast Cancer
Jules Bordet Institute 65
Load More Results